Newsfeeds Archive - Spark Newswire

4 minute read

Acrivon Therapeutics Reports Initial Positive Clinical Data For ACR-368 And Pipeline Program Progress Today At Corporate R&D Event

April 24, 4:44 PM

• Initial ACR-368 Phase 2b clinical data in patients with ovarian or endometrial cancers (n=26; 10 OncoSignature-positive and 16 OncoSignature-negative) are being presented• A 50% confirmed overall

ACRV

1 minute read

Movers

12 Health Care Stocks Moving In Wednesday’s After-Market Session

By Benzinga Insights

April 24, 4:31 PM

Gainers Acrivon Therapeutics (NASDAQ:ACRV) stock rose 12.3% to $10.67 during Wednesday’s after-market session. The market value of their…

ACRV

3 minute read

Acrivon Therapeutics Presents Data At AACR Annual Meeting Highlighting Capabilities Of Acrivon Predictive Precision Proteomics For The Discovery Of ACR-2316, A Novel, Selective WEE1/PKMYT1 Inhibitor, And The Identification Of Actionable Resistance Mech…

By Benzinga Newsdesk

April 10, 8:07 AM

ACR-2316, which was internally discovered using biological SAR enabled by AP3 to overcome limitations of benchmark clinical WEE1 and PKMYT1 inhibitors, demonstrates potent anticancer activity in preclinical studies and

ACRV

3 minute read

Crude Oil Down Over 1%; Cognyte Software Shares Plummet

By Avi Kapoor

April 9, 2:34 PM

U.S. stocks traded lower toward the end of trading, with the S&P 500 falling around 0.4% on Tuesday. The Dow traded down 0.46% to 38,713.72 while the NASDAQ fell 0.24% to 16,215.32. The S&P 500 also fell, dropping, 0.39% to 5,182.36.

ACRV

4 minute read

Why Tilray Brands Shares Are Trading Lower By Around 22%? Here Are Other Stocks Moving In Tuesday’s Mid-Day Session

By Avi Kapoor

April 9, 1:12 PM

Shares of Tilray Brands, Inc. (NASDAQ: TLRY) fell sharply during Tuesday’s session after the company missed third-quarter estimates and said it no longer expects to generate positive adjusted free

ACB

2 minute read

Movers

12 Health Care Stocks Moving In Tuesday’s Intraday Session

By Benzinga Insights

April 9, 12:31 PM

Gainers Acrivon Therapeutics (NASDAQ:ACRV) stock moved upwards by 72.0% to $10.16 during Tuesday’s regular session. The market value…

ACOR

3 minute read

Dow Dips 150 Points; Laser Photonics Shares Spike Higher

By Avi Kapoor

April 9, 12:05 PM

U.S. stocks traded lower midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded down 0.39% to 38,742.12 while the NASDAQ fell 0.16% to 16,227.77. The S&P 500 also fell, dropping, 0.29% to 5,187.10.

ACRV

2 minute read

Acrivon Therapeutics Stock Is Soaring Tuesday: What’s Going On?

By Adam Eckert

April 9, 9:52 AM

Acrivon Therapeutics has entered into a securities purchase agreement to issue and sell 8.235 million shares of its common stock at a price of $8.50 per share, as well as pre-funded warrants to purchase up to 7.06 million shares through a private investment in public equity (PIPE) financing.

ACRV

3 minute read

Dow Gains Over 50 Points; Neogen Posts Downbeat Earnings

By Avi Kapoor

April 9, 9:51 AM

U.S. stocks traded higher this morning, with the Dow Jones index gaining over 50 points on Tuesday. Following the market opening Tuesday, the Dow traded up 0.20% to 38,972.32 while the NASDAQ rose 0.40% to 16,319.23. The S&P 500 also rose, gaining, 0.32% to 5,219.29.

ACRV